CFAR 2003 Symposium: Immunology of HIV Infection

Add to Calendar 2003-10-22 08:00 2003-10-23 17:00 America/Los_Angeles CFAR 2003 Symposium: Immunology of HIV Infection Mahley Auditorium, Gladstone Institutes , Mission Bay

This year's symposium focused on new developments in basic biological research regarding the immunology of HIV infection.

Keynote Address

  • Natural Killer Cells and Immunity to Viral Infection
    Lewis Lanier, PhD, UCSF


  • Innate Immunity is Important in Preventing HIV Infection and Disease Progression
    Jay A. Levy, MD, UCSF
  • T Cell Activation Versus Virus Dissemination by Virus-Bearing Dendritic Cells
    Melissa Pope, PhD, Center for Biomedical Research, Population Council
  • T Cell Depletion in HIV-1 Infection
    Mette Hazenberg, MD, PhD, Gladstone Institute of Virology and Immunology
  • T Cell Proliferation Failure in HIV Disease: Implications for Immune Restoration
    Michael Lederman, MD, Case Western Reserve University
  • Regulation of HIV specific CD8+ T cells
    Douglas F. Nixon, MD, PhD, Gladstone Institute of Virology and Immunology, UCSF
  • Generation of Dysfunctional CD8low T Cells in the Setting of HIV Infection
    David Favre, DVM, PhD, Gladstone Institute of Virology and Immunology
  • Dendritic Cells in HIV Pathogenesis
    Dan R. Littman, MD, PhD, Howard Hughes Medical Institute, Skirball Institute of Biomolecular Medicine, New York University
  • Antiviral Memory T Cell Responses
    Giuseppe Pantaleo, MD, University of Lausanne
  • Selection by SIV-Specific CTL
    David Watkins, PhD, University of Wisconsin Madison Medical School
  • Differential Thresholds for Cytokine and Lytic Effector Functions of Virus-Specific CD8+ T Cells
    Richard A. Koup, MD, Vaccine Research Center, NIAID/NIH
  • SHIV Escape from Cytotoxic Lymphocyte Recognition in Rhesus Monkeys
    Norman L. Letvin, MD, Professor of Medicine, Beth Israel Deaconess Medical Center, Harvard University
  • The Effects of Growth Hormone on T Lymphopoiesis
    Laura A. Napolitano, MD, Gladstone Institute of Virology and Immunology
  • The Pre-Clinical Development and Properties of HIV-1 Entry Inhibitors as Drugs and/or Microbicides
    John P. Moore, PhD, Weill Medical College of Cornell University